{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T20:09:59Z","timestamp":1771618199915,"version":"3.50.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI165618"],"award-info":[{"award-number":["R01 AI165618"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DP2-AI171122"],"award-info":[{"award-number":["DP2-AI171122"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 AI105867"],"award-info":[{"award-number":["R21 AI105867"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011138","name":"AgBioResearch, Michigan State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011138","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Utah Office of the Vice President"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Antimicrob Resist"],"DOI":"10.1038\/s44259-025-00124-0","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T08:11:52Z","timestamp":1749888712000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Defining the mechanism of action of the nitrofuranyl piperazine HC2210 against Mycobacterium abscessus"],"prefix":"10.1038","volume":"3","author":[{"given":"Ifeanyichukwu E.","family":"Eke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bassel J.","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soledad","family":"Soverina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Olive","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nico","family":"Cicchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison F.","family":"Carey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert B.","family":"Abramovitch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,14]]},"reference":[{"key":"124_CR1","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41579-020-0331-1","volume":"18","author":"MD Johansen","year":"2020","unstructured":"Johansen, M. D., Herrmann, J. L. & Kremer, L. Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus. Nat. Rev. Microbiol. 18, 392\u2013407 (2020).","journal-title":"Nat. Rev. Microbiol."},{"key":"124_CR2","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1093\/jac\/dkr578","volume":"67","author":"R Nessar","year":"2012","unstructured":"Nessar, R., Cambau, E., Reyrat, J. M., Murray, A. & Gicquel, B. Mycobacterium abscessus: a new antibiotic nightmare. J. Antimicrob. Chemother. 67, 810\u2013818 (2012).","journal-title":"J. Antimicrob. Chemother."},{"key":"124_CR3","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1080\/17460441.2019.1629414","volume":"14","author":"US Ganapathy","year":"2019","unstructured":"Ganapathy, U. S., Dartois, V. & Dick, T. Repositioning rifamycins for Mycobacterium abscessus lung disease. Expert Opin. Drug Discov. 14, 867\u2013878 (2019).","journal-title":"Expert Opin. Drug Discov."},{"key":"124_CR4","doi-asserted-by":"publisher","first-page":"e0047423","DOI":"10.1128\/aac.00474-23","volume":"67","author":"IE Eke","year":"2023","unstructured":"Eke, I. E. et al. Discovery and characterization of antimycobacterial nitro-containing compounds with distinct mechanisms of action and in vivo efficacy. Antimicrob. Agents Chemother. 67, e0047423 (2023).","journal-title":"Antimicrob. Agents Chemother."},{"key":"124_CR5","doi-asserted-by":"publisher","unstructured":"Eke, I. E. & Abramovitch, R. B. Functions of nitroreductases in mycobacterial physiology and drug susceptibility. J. Bacteriol. https:\/\/doi.org\/10.1128\/jb.00326-24:e0032624 (2025).","DOI":"10.1128\/jb.00326-24:e0032624"},{"key":"124_CR6","doi-asserted-by":"crossref","unstructured":"Bellerose, M. M. et al. Common variants in the glycerol kinase gene reduce tuberculosis drug efficacy. mBio 10, e00663-19 (2019).","DOI":"10.1128\/mBio.00663-19"},{"key":"124_CR7","doi-asserted-by":"publisher","first-page":"19665","DOI":"10.1073\/pnas.1907631116","volume":"116","author":"H Safi","year":"2019","unstructured":"Safi, H. et al. Phase variation in Mycobacterium tuberculosis glpK produces transiently heritable drug tolerance. Proc. Natl Acad. Sci USA 116, 19665\u201319674 (2019).","journal-title":"Proc. Natl Acad. Sci USA"},{"key":"124_CR8","doi-asserted-by":"crossref","unstructured":"Chen, Y. et al. Novel mutations associated with clofazimine resistance in Mycobacterium abscessus. Antimicrob. Agents Chemother. 62, e00544-18 (2018).","DOI":"10.1128\/AAC.00544-18"},{"key":"124_CR9","doi-asserted-by":"crossref","unstructured":"Aziz, D. B. et al. Rifabutin is active against Mycobacterium abscessus complex. Antimicrob. Agents Chemother. 61, e00155-17 (2017).","DOI":"10.1128\/AAC.00155-17"},{"key":"124_CR10","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/jac\/dkw466","volume":"72","author":"A Rominski","year":"2017","unstructured":"Rominski, A., Roditscheff, A., Selchow, P., Bottger, E. C. & Sander, P. Intrinsic rifamycin resistance of Mycobacterium abscessus is mediated by ADP-ribosyltransferase MAB_0591. J. Antimicrob. Chemother. 72, 376\u2013384 (2017).","journal-title":"J. Antimicrob. Chemother."},{"key":"124_CR11","doi-asserted-by":"publisher","first-page":"815","DOI":"10.2147\/IDR.S240716","volume":"13","author":"F Zhang","year":"2020","unstructured":"Zhang, F. et al. Comparison of in vitro susceptibility of mycobacteria against PA-824 to identify key residues of Ddn, the deazoflavin-dependent nitroreductase from Mycobacterium tuberculosis. Infect. Drug Resist. 13, 815\u2013822 (2020).","journal-title":"Infect. Drug Resist."},{"key":"124_CR12","doi-asserted-by":"publisher","first-page":"e0151421","DOI":"10.1128\/AAC.01514-21","volume":"65","author":"US Ganapathy","year":"2021","unstructured":"Ganapathy, U. S. et al. A Mycobacterium tuberculosis NBTI DNA gyrase inhibitor is active against Mycobacterium abscessus. Antimicrob. Agents Chemother. 65, e0151421 (2021).","journal-title":"Antimicrob. Agents Chemother."},{"key":"124_CR13","doi-asserted-by":"crossref","unstructured":"Sarathy, J. P. et al. TBAJ-876, a 3,5-dialkoxypyridine analogue of bedaquiline, is active against Mycobacterium abscessus. Antimicrob. Agents Chemother. 64, e02404-19 (2020)","DOI":"10.1128\/AAC.02404-19"},{"key":"124_CR14","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1093\/jac\/dku431","volume":"70","author":"BE Ferro","year":"2015","unstructured":"Ferro, B. E., van Ingen, J., Wattenberg, M., van Soolingen, D. & Mouton, J. W. Time-kill kinetics of antibiotics active against rapidly growing mycobacteria. J. Antimicrob. Chemother. 70, 811\u2013817 (2015).","journal-title":"J. Antimicrob. Chemother."},{"key":"124_CR15","doi-asserted-by":"publisher","unstructured":"Yang, T. et al. Genomic analysis of global Mycobacterium abscessus isolates reveals ongoing evolution of drug-resistance-associated genes. J. Infect. Dis. https:\/\/doi.org\/10.1093\/infdis\/jiae580 (2024).","DOI":"10.1093\/infdis\/jiae580"},{"key":"124_CR16","doi-asserted-by":"publisher","first-page":"5316","DOI":"10.1128\/AAC.00308-15","volume":"59","author":"HL Haver","year":"2015","unstructured":"Haver, H. L. et al. Mutations in genes for the F420 biosynthetic pathway and a nitroreductase enzyme are the primary resistance determinants in spontaneous in vitro-selected PA-824-resistant mutants of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 59, 5316\u20135323 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"124_CR17","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1742-4658.2011.08404.x","volume":"279","author":"M Gurumurthy","year":"2012","unstructured":"Gurumurthy, M. et al. Substrate specificity of the deazaflavin-dependent nitroreductase from Mycobacterium tuberculosis responsible for the bioreductive activation of bicyclic nitroimidazoles. FEBS J. 279, 113\u2013125 (2012).","journal-title":"FEBS J."},{"key":"124_CR18","doi-asserted-by":"crossref","unstructured":"Rifat, D. et al. Mutations in fbiD (Rv2983) as a novel determinant of resistance to pretomanid and delamanid in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 65, e01948-20 (2020).","DOI":"10.1128\/AAC.01948-20"},{"key":"124_CR19","doi-asserted-by":"publisher","first-page":"e1008287","DOI":"10.1371\/journal.ppat.1008287","volume":"16","author":"BM Lee","year":"2020","unstructured":"Lee, B. M. et al. Predicting nitroimidazole antibiotic resistance mutations in Mycobacterium tuberculosis with protein engineering. PLoS Pathog. 16, e1008287 (2020).","journal-title":"PLoS Pathog."},{"key":"124_CR20","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1073\/pnas.0508392103","volume":"103","author":"UH Manjunatha","year":"2006","unstructured":"Manjunatha, U. H. et al. Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA 103, 431\u2013436 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"124_CR21","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1126\/science.1164571","volume":"322","author":"R Singh","year":"2008","unstructured":"Singh, R. et al. PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release. Science 322, 1392\u20131395 (2008).","journal-title":"Science"},{"key":"124_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1060","volume":"1","author":"K Pethe","year":"2010","unstructured":"Pethe, K. et al. A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy. Nat. Commun. 1, 57 (2010).","journal-title":"Nat. Commun."},{"key":"124_CR23","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/1751-7915.13400","volume":"13","author":"I Poblete-Castro","year":"2020","unstructured":"Poblete-Castro, I., Wittmann, C. & Nikel, P. I. Biochemistry, genetics and biotechnology of glycerol utilization in Pseudomonas species. Microb. Biotechnol. 13, 32\u201353 (2020).","journal-title":"Microb. Biotechnol."},{"key":"124_CR24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.tube.2010.09.006","volume":"91","author":"A Kapopoulou","year":"2011","unstructured":"Kapopoulou, A., Lew, J. M. & Cole, S. T. The MycoBrowser portal: a comprehensive and manually annotated resource for mycobacterial genomes. Tuberculosis 91, 8\u201313 (2011).","journal-title":"Tuberculosis"},{"key":"124_CR25","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1080\/07391102.2013.826143","volume":"32","author":"X Fan","year":"2014","unstructured":"Fan, X., Tang, X., Yan, J. & Xie, J. Identification of idiosyncratic Mycobacterium tuberculosis ribosomal protein subunits with implications in extraribosomal function, persistence, and drug resistance based on transcriptome data. J. Biomol. Struct. Dyn. 32, 1546\u20131551 (2014).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"124_CR26","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.chembiol.2007.04.005","volume":"14","author":"F Wang","year":"2007","unstructured":"Wang, F., Langley, R., Gulten, G., Wang, L. & Sacchettini, J. C. Identification of a type III thioesterase reveals the function of an operon crucial for Mtb virulence. Chem. Biol. 14, 543\u2013551 (2007).","journal-title":"Chem. Biol."},{"key":"124_CR27","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1472-765X.2005.01659.x","volume":"40","author":"SJ Waddell","year":"2005","unstructured":"Waddell, S. J. et al. Inactivation of polyketide synthase and related genes results in the loss of complex lipids in Mycobacterium tuberculosis H37Rv. Lett. Appl. Microbiol. 40, 201\u2013206 (2005).","journal-title":"Lett. Appl. Microbiol."},{"key":"124_CR28","doi-asserted-by":"publisher","first-page":"5120","DOI":"10.1016\/j.jmb.2018.09.017","volume":"430","author":"PC Nguyen","year":"2018","unstructured":"Nguyen, P. C. et al. Biochemical and structural characterization of TesA, a major thioesterase required for outer-envelope lipid biosynthesis in Mycobacterium tuberculosis. J. Mol. Biol. 430, 5120\u20135136 (2018).","journal-title":"J. Mol. Biol."},{"key":"124_CR29","doi-asserted-by":"publisher","first-page":"30634","DOI":"10.1074\/jbc.M404011200","volume":"279","author":"J Buglino","year":"2004","unstructured":"Buglino, J., Onwueme, K. C., Ferreras, J. A., Quadri, L. E. & Lima, C. D. Crystal structure of PapA5, a phthiocerol dimycocerosyl transferase from Mycobacterium tuberculosis. J. Biol. Chem. 279, 30634\u201330642 (2004).","journal-title":"J. Biol. Chem."},{"key":"124_CR30","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1099\/mic.0.057869-0","volume":"158","author":"SS Chavadi","year":"2012","unstructured":"Chavadi, S. S. et al. The mycobacterial acyltransferase PapA5 is required for biosynthesis of cell wall-associated phenolic glycolipids. Microbiology 158, 1379\u20131387 (2012).","journal-title":"Microbiology"},{"key":"124_CR31","doi-asserted-by":"publisher","first-page":"5172","DOI":"10.1074\/jbc.RA117.000246","volume":"293","author":"J Madacki","year":"2018","unstructured":"Madacki, J. et al. Impact of the epoxide hydrolase EphD on the metabolism of mycolic acids in mycobacteria. J. Biol. Chem. 293, 5172\u20135184 (2018).","journal-title":"J. Biol. Chem."},{"key":"124_CR32","doi-asserted-by":"publisher","first-page":"215","DOI":"10.4161\/cib.2.3.7926","volume":"2","author":"U Manjunatha","year":"2009","unstructured":"Manjunatha, U., Boshoff, H. I. & Barry, C. E. The mechanism of action of PA-824: Novel insights from transcriptional profiling. Commun. Integr. Biol. 2, 215\u2013218 (2009).","journal-title":"Commun. Integr. Biol."},{"key":"124_CR33","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.chembiol.2019.10.010","volume":"27","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. Antitubercular triazines: optimization and intrabacterial metabolism. Cell Chem. Biol. 27, 172\u2013185.e11 (2020).","journal-title":"Cell Chem. Biol."},{"key":"124_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.tube.2019.05.002","volume":"117","author":"A Van den Bossche","year":"2019","unstructured":"Van den Bossche, A. et al. Transcriptional profiling of a laboratory and clinical Mycobacterium tuberculosis strain suggests respiratory poisoning upon exposure to delamanid. Tuberculosis 117, 18\u201323 (2019).","journal-title":"Tuberculosis"},{"key":"124_CR35","doi-asserted-by":"publisher","first-page":"12833","DOI":"10.1073\/pnas.96.22.12833","volume":"96","author":"M Wilson","year":"1999","unstructured":"Wilson, M. et al. Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization. Proc. Natl Acad. Sci. USA 96, 12833\u201312838 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"124_CR36","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1107\/S2059798318017242","volume":"75","author":"JAG Cox","year":"2019","unstructured":"Cox, J. A. G. et al. Crystal structure of Mycobacterium tuberculosis FadB2 implicated in mycobacterial beta-oxidation. Acta Crystallogr. D Struct. Biol. 75, 101\u2013108 (2019).","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"124_CR37","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.3389\/fmicb.2018.01184","volume":"9","author":"D Dutta","year":"2018","unstructured":"Dutta, D. Advance in research on Mycobacterium tuberculosis FabG4 and its inhibitor. Front. Microbiol. 9, 1184 (2018).","journal-title":"Front. Microbiol."},{"key":"124_CR38","doi-asserted-by":"publisher","first-page":"5669","DOI":"10.1021\/acs.biochem.5b00911","volume":"54","author":"R Lu","year":"2015","unstructured":"Lu, R., Schmitz, W. & Sampson, N. S. alpha-Methyl Acyl CoA racemase provides Mycobacterium tuberculosis catabolic access to cholesterol esters. Biochemistry 54, 5669\u20135672 (2015).","journal-title":"Biochemistry"},{"key":"124_CR39","doi-asserted-by":"crossref","unstructured":"Lee, C. L., Ng, H. F., Ngeow, Y. F. & Thaw, Z. A stop-gain mutation in sigma factor SigH (MAB_3543c) may be associated with tigecycline resistance in Mycobacteroides abscessus. J. Med. Microbiol. 70 (2021).","DOI":"10.1099\/jmm.0.001378"},{"key":"124_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.chom.2010.12.004","volume":"9","author":"A Venugopal","year":"2011","unstructured":"Venugopal, A. et al. Virulence of Mycobacterium tuberculosis depends on lipoamide dehydrogenase, a member of three multienzyme complexes. Cell Host Microbe 9, 21\u201331 (2011).","journal-title":"Cell Host Microbe"},{"key":"124_CR41","doi-asserted-by":"publisher","first-page":"e1701881","DOI":"10.1126\/sciadv.1701881","volume":"3","author":"M Cokol","year":"2017","unstructured":"Cokol, M., Kuru, N., Bicak, E., Larkins-Ford, J. & Aldridge, B. B. Efficient measurement and factorization of high-order drug interactions in Mycobacterium tuberculosis. Sci. Adv. 3, e1701881 (2017).","journal-title":"Sci. Adv."},{"key":"124_CR42","doi-asserted-by":"publisher","first-page":"e0367723","DOI":"10.1128\/spectrum.03677-23","volume":"12","author":"JT Williams","year":"2024","unstructured":"Williams, J. T. et al. The Mycobacterium tuberculosis MmpL3 inhibitor MSU-43085 is active in a mouse model of infection. Microbiol. Spectr. 12, e0367723 (2024).","journal-title":"Microbiol. Spectr."},{"key":"124_CR43","doi-asserted-by":"publisher","unstructured":"Anaya-Sanchez, A. et al. Methylglyoxal is an antibacterial effector produced by macrophages during infection. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.11.03.621721 (2024).","DOI":"10.1101\/2024.11.03.621721"},{"key":"124_CR44","doi-asserted-by":"publisher","first-page":"e1007223","DOI":"10.1371\/journal.ppat.1007223","volume":"14","author":"V Guerrini","year":"2018","unstructured":"Guerrini, V. et al. Storage lipid studies in tuberculosis reveal that foam cell biogenesis is disease-specific. PLoS Pathog. 14, e1007223 (2018).","journal-title":"PLoS Pathog."},{"key":"124_CR45","doi-asserted-by":"publisher","first-page":"e1002093","DOI":"10.1371\/journal.ppat.1002093","volume":"7","author":"J Daniel","year":"2011","unstructured":"Daniel, J., Maamar, H., Deb, C., Sirakova, T. D. & Kolattukudy, P. E. Mycobacterium tuberculosis uses host triacylglycerol to accumulate lipid droplets and acquires a dormancy-like phenotype in lipid-loaded macrophages. PLoS Pathog. 7, e1002093 (2011).","journal-title":"PLoS Pathog."},{"key":"124_CR46","doi-asserted-by":"crossref","unstructured":"Roux, A. L. et al. The distinct fate of smooth and rough Mycobacterium abscessus variants inside macrophages. Open Biol. 6, 160185 (2016).","DOI":"10.1098\/rsob.160185"},{"key":"124_CR47","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1128\/JCM.01249-13","volume":"52","author":"K Ruger","year":"2014","unstructured":"Ruger, K. et al. Characterization of rough and smooth morphotypes of Mycobacterium abscessus isolates from clinical specimens. J. Clin. Microbiol. 52, 244\u2013250 (2014).","journal-title":"J. Clin. Microbiol."},{"key":"124_CR48","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1128\/JCM.01144-14","volume":"52","author":"RM Davidson","year":"2014","unstructured":"Davidson, R. M. et al. Genome sequencing of Mycobacterium abscessus isolates from patients in the united states and comparisons to globally diverse clinical strains. J. Clin. Microbiol. 52, 3573\u20133582 (2014).","journal-title":"J. Clin. Microbiol."},{"key":"124_CR49","doi-asserted-by":"publisher","first-page":"e81985","DOI":"10.1371\/journal.pone.0081985","volume":"8","author":"E Purwantini","year":"2013","unstructured":"Purwantini, E. & Mukhopadhyay, B. Rv0132c of Mycobacterium tuberculosis encodes a coenzyme F420-dependent hydroxymycolic acid dehydrogenase. PLoS ONE 8, e81985 (2013).","journal-title":"PLoS ONE"},{"key":"124_CR50","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/35016103","volume":"405","author":"CK Stover","year":"2000","unstructured":"Stover, C. K. et al. A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis. Nature 405, 962\u2013966 (2000).","journal-title":"Nature"},{"key":"124_CR51","doi-asserted-by":"publisher","first-page":"e0152145","DOI":"10.1371\/journal.pone.0152145","volume":"11","author":"JD Sharp","year":"2016","unstructured":"Sharp, J. D. et al. Comprehensive definition of the SigH regulon of Mycobacterium tuberculosis reveals transcriptional control of diverse stress responses. PLoS ONE 11, e0152145 (2016).","journal-title":"PLoS ONE"},{"key":"124_CR52","doi-asserted-by":"publisher","first-page":"6119","DOI":"10.1128\/JB.183.20.6119-6125.2001","volume":"183","author":"S Raman","year":"2001","unstructured":"Raman, S. et al. The alternative sigma factor SigH regulates major components of oxidative and heat stress responses in Mycobacterium tuberculosis. J. Bacteriol. 183, 6119\u20136125 (2001).","journal-title":"J. Bacteriol."},{"key":"124_CR53","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.chembiol.2017.06.018","volume":"24","author":"GB Coulson","year":"2017","unstructured":"Coulson, G. B. et al. Targeting Mycobacterium tuberculosis sensitivity to thiol stress at acidic pH kills the bacterium and potentiates antibiotics. Cell Chem. Biol. 24, 993\u20131004.e4 (2017).","journal-title":"Cell Chem. Biol."},{"key":"124_CR54","doi-asserted-by":"publisher","first-page":"20089","DOI":"10.1039\/D1RA03181C","volume":"11","author":"SJ Dechow","year":"2021","unstructured":"Dechow, S. J., Coulson, G. B., Wilson, M. W., Larsen, S. D. & Abramovitch, R. B. AC2P20 selectively kills Mycobacterium tuberculosis at acidic pH by depleting free thiols. RSC Adv. 11, 20089\u201320100 (2021).","journal-title":"RSC Adv."},{"key":"124_CR55","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1099\/jmm.0.000857","volume":"67","author":"HF Ng","year":"2018","unstructured":"Ng, H. F., Tan, J. L., Zin, T., Yap, S. F. & Ngeow, Y. F. A mutation in anti-sigma factor MAB_3542c may be responsible for tigecycline resistance in Mycobacterium abscessus. J. Med. Microbiol. 67, 1676\u20131681 (2018).","journal-title":"J. Med. Microbiol."},{"key":"124_CR56","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1074\/jbc.RA118.005732","volume":"294","author":"BS Lee","year":"2019","unstructured":"Lee, B. S. et al. Inhibitors of energy metabolism interfere with antibiotic-induced death in mycobacteria. J. Biol. Chem. 294, 1936\u20131943 (2019).","journal-title":"J. Biol. Chem."},{"key":"124_CR57","doi-asserted-by":"publisher","first-page":"e0009023","DOI":"10.1128\/aac.00090-23","volume":"67","author":"N Van","year":"2023","unstructured":"Van, N. et al. Novel synergies and isolate specificities in the drug interaction landscape of Mycobacterium abscessus. Antimicrob. Agents Chemother. 67, e0009023 (2023).","journal-title":"Antimicrob. Agents Chemother."},{"key":"124_CR58","doi-asserted-by":"publisher","first-page":"211801","DOI":"10.1103\/PhysRevLett.105.211801","volume":"105","author":"V Khachatryan","year":"2010","unstructured":"Khachatryan, V. et al. Search for dijet resonances in 7 TeV pp collisions at CMS. Phys. Rev. Lett. 105, 211801 (2010).","journal-title":"Phys. Rev. Lett."},{"key":"124_CR59","doi-asserted-by":"publisher","first-page":"e00547","DOI":"10.1128\/AAC.00547-19","volume":"63","author":"JT Williams","year":"2019","unstructured":"Williams, J. T. et al. Identification of new MmpL3 inhibitors by untargeted and targeted mutant screens defines MmpL3 domains with differential resistance. Antimicrob. Agents Chemother. 63, e00547\u201319 (2019).","journal-title":"Antimicrob. Agents Chemother."},{"key":"124_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-15-1039","volume":"15","author":"JE Barrick","year":"2014","unstructured":"Barrick, J. E. et al. Identifying structural variation in haploid microbial genomes from short-read resequencing data using breseq. BMC Genomics 15, 1039 (2014).","journal-title":"BMC Genomics"},{"key":"124_CR61","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/978-1-4939-0554-6_12","volume":"1151","author":"DE Deatherage","year":"2014","unstructured":"Deatherage, D. E. & Barrick, J. E. Identification of mutations in laboratory-evolved microbes from next-generation sequencing data using breseq. Methods Mol. Biol. 1151, 165\u2013188 (2014).","journal-title":"Methods Mol. Biol."},{"key":"124_CR62","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/mmi.12688","volume":"94","author":"JJ Baker","year":"2014","unstructured":"Baker, J. J., Johnson, B. K. & Abramovitch, R. B. Slow growth of Mycobacterium tuberculosis at acidic pH is regulated by phoPR and host-associated carbon sources. Mol. Microbiol. 94, 56\u201369 (2014).","journal-title":"Mol. Microbiol."},{"key":"124_CR63","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.chom.2007.09.006","volume":"2","author":"KH Rohde","year":"2007","unstructured":"Rohde, K. H., Abramovitch, R. B. & Russell, D. G. Mycobacterium tuberculosis invasion of macrophages: linking bacterial gene expression to environmental cues. Cell Host Microbe 2, 352\u2013364 (2007).","journal-title":"Cell Host Microbe"}],"container-title":["npj Antimicrobials and Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44259-025-00124-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44259-025-00124-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44259-025-00124-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T09:03:00Z","timestamp":1749891780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44259-025-00124-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,14]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["124"],"URL":"https:\/\/doi.org\/10.1038\/s44259-025-00124-0","relation":{},"ISSN":["2731-8745"],"issn-type":[{"value":"2731-8745","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,14]]},"assertion":[{"value":"28 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.B.A. is the owner of Tarn Biosciences, Inc., a company that is working to develop new antimycobacterial drugs. I.E.E. and R.B.A. are inventors on a patent application related to this work. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}